The US National Association of Boards of Pharmacy has released a position paper examining the "flagrant lawlessness" of web sites selling prescription medicine over the Internet. "To see why this 'Wild ' of an electronic marketplace is a problem, one need only follow the trail of dead and injured patients," the paper asserts. The State of the Internet: NABP Position Paper on the Continued Proliferation of Rogue Internet Drug Outlets calls to task the various parties whose activities allow this trend to continue and challenges lawmakers and regulators to rein in this dangerous underground marketplace.
In the document, the NABP revisits the call to action of its 2003 Position Paper on the Importation of Foreign Prescription Drugs, which states that "purchasing medications from unknown and illegal sources via the Internet and other means is compromising the US medication distribution system and making US citizens vulnerable to bioterrorism attacks." The 2009 position paper notes that, "in the six years since NABP called attention to this situation, little has changed."
The current position paper clearly elucidates the laws and practice standards pertaining to the dispensing of prescription medicine and poses the question, "so then why, out of 1,351 Internet drug outlets assessed by NABP as of January 2009, do 1,183 (88%) of them continue, unhindered, to offer prescription drugs without a valid prescription?" The paper goes on to identify several avenues through which rogue Internet drug outlets continue to skirt the laws established to protect patient health and safety.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze